• Profile
Close

Outcomes following parathyroidectomy for secondary hyperparathyroidism in patients with chronic kidney disease – A single‐center study

Internal Medicine Journal Aug 06, 2021

Bali P, Toussaint ND, Tiong MK, et al. - Parathyroidectomy for severe and refractory secondary hyperparathyroidism (SHPT) is commonly followed by significant fluctuations in serum calcium levels in patients with chronic kidney disease (CKD), however, the present cohort experienced lower long-term morbidity and mortality than described in previous reports. This highlights that in a carefully selected cohort, parathyroidectomy can be safely performed for severe SHPT refractory to medical treatment.

  • Researchers assessed 129 patients (mean age 50.7 ± 15 years, 109 (85%) on dialysis) undergoing parathyroidectomy for SHPT during the 10-year study period.

  • Significant immediate post operative complications occurred in 6%, requiring admission to the intensive care unit or return to theatre.

  • Hospital readmission was required in 19% within the first 6 months.

  • At least one episode of hypercalcemia (corrected calcium > 2.6 mmol/L) or hypocalcemia (corrected calcium < 2.1 mmol/L) occurred in 78% and 80%, respectively, within 12 months post parathyroidectomy.

  • Over a 12-month period, 5% died, and 6% experienced a major cardiovascular event.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay